Physical, but not laboratory, treatment-related adverse events are associated with favorable outcomes of enfortumab vedotin for advanced urothelial carcinoma: A landmark analysis
一项里程碑式分析表明,与治疗相关的生理不良事件(而非实验室不良事件)与恩福妥单抗治疗晚期尿路上皮癌的良好预后相关:
期刊:International Journal of Urology
影响因子:2.2
doi:10.1111/iju.15640
Taguchi, Satoru; Kawai, Taketo; Ambe, Yoshiki; Kishitani, Kenjiro; Noda, Michio; Kaneko, Tomoyuki; Miyakawa, Jimpei; Nakamura, Yu; Hoshina, Hayato; Obinata, Daisuke; Yamaguchi, Kenya; Kakutani, Shigenori; Furuya, Yoshitsune; Sato, Yujiro; Adachi, Yume; Sugimoto, Kazuma; Sato, Keigo; Tabata, Mariko; Tanaka, Takehiro; Nara, Katsuhiko; Uemura, Yukari; Kamei, Jun; Akiyama, Yoshiyuki; Sato, Yusuke; Yamada, Yuta; Niimi, Aya; Yamada, Daisuke; Takada, Tappei; Takahashi, Sayuri; Yamada, Yukio; Miyazaki, Hideyo; Enomoto, Yutaka; Nishimatsu, Hiroaki; Fujimura, Tetsuya; Fukuhara, Hiroshi; Nakagawa, Tohru; Takahashi, Satoru; Kume, Haruki